Orserdu 345 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQT8X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,041
Award facts
- Contract value 100% obligated
- $27,041.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27,041.46 to AmerSourceBergen Drug Corp on January 8, 2026, for the supply of Orserdu 345 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by January 30, 2026. The work will be performed at AmerSourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerSourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company demonstrates significant capability in fulfilling diverse pharmaceutical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This particular delivery order for Orserdu represents one of numerous task orders executed under the DLA Troop Support Medical IDC, reflecting AmerSourceBergen's role as a primary pharmaceutical supplier to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FQT8X?
SPE2DR26FQT8X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FQT8X worth?
The government has obligated $27,041 on SPE2DR26FQT8X.
Is contract SPE2DR26FQT8X an order under another contract?
Yes. SPE2DR26FQT8X is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT8X competed?
The extent of competition for SPE2DR26FQT8X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award